Case

Severe Aortic Stenosis: What Matters Before Non-Cardiac Surgery?

When severe AS is already known, the challenge is not diagnosing it again. The challenge is deciding how it should influence perioperative planning — and who needs to be in that conversation.

Clinical scenario

A 78-year-old man with known severe aortic stenosis (AVA 0.7 cm², Vmax 4.2 m/s) is scheduled for elective total hip replacement. Recent echocardiogram: LVEF 58%. He reports exertional dyspnea (NYHA II). No syncope or chest pain. How should severe AS influence the perioperative plan?

HR 74, BP 134/78. No history of prior valve intervention. Most recent cardiology review was at the time of the last echocardiogram.

When to use this page

When severe AS is already established and you need to determine how it should influence perioperative planning. This page is NOT for grading AS severity or calculating valve parameters — those belong to the dedicated AS tools. This page focuses on perioperative decision-making after the diagnosis is confirmed.

Why symptoms matter more than another valve measurement

Key point

When severe AS is confirmed, the next clinical task is not to remeasure AVA or Vmax. The next task is to determine what severe AS means for this specific operation, this patient, and this timeline.

Perioperative planning for severe AS rests on four pillars: symptom status, surgical urgency, valve intervention candidacy, and multidisciplinary coordination. Echocardiographic severity is the starting point — not the conclusion.

Symptom status: the most important first question

Key point

Symptomatic severe AS and asymptomatic severe AS represent fundamentally different clinical situations. In this patient, NYHA II dyspnea makes this symptomatic severe AS — and that changes everything.

  • Dyspnea (exertional or at rest)
  • Chest pain (exertional angina)
  • Syncope or presyncope
  • Reduced exercise tolerance

The classic triad of severe AS — dyspnea, angina, syncope — is not just a diagnostic feature. It signals that the heart is no longer compensating adequately. This patient's NYHA II dyspnea places him in the symptomatic category, which directly influences the decision about whether non-cardiac surgery should proceed before valve intervention.

The importance of surgical urgency

Key point

Surgical urgency often determines the management strategy more than the valve gradient itself. Elective surgery allows time for valve assessment. Emergency surgery does not.

  • Elective surgery → assess valve intervention candidacy first; determine surgical timing afterward
  • Emergency surgery → cannot wait for valve treatment; optimize hemodynamic management and proceed

Should valve intervention come first?

Key point

In symptomatic severe AS, TAVI or SAVR may need to precede non-cardiac surgery. The question is not 'can anesthesia handle this?' The question is 'would this patient be safer after valve treatment?'

For detailed valve-specific assessment — including severity classification, TAVI vs SAVR selection, and intervention criteria — use the dedicated Aortic Stenosis tools. This case focuses on the perioperative decision-making layer.

Why preserved EF can be misleading

Key point

LVEF 58% confirms preserved systolic function. It does not confirm perioperative safety. A normal ejection fraction does not neutralize severe valve obstruction.

In severe AS, cardiac output is relatively fixed by the obstruction itself. Even with preserved EF, the heart cannot easily increase output in response to the hemodynamic demands of surgery and anesthesia. Preload reduction, vasodilation, and tachycardia are all poorly tolerated. The preserved EF tells you the pump is working — it does not tell you the pump can handle the perioperative stress.

Multidisciplinary decision-making

Key point

Severe AS is not a problem anesthesia manages alone. The most important first step may be deciding who needs to be in the conversation.

  • Cardiology: valve intervention candidacy, perioperative risk assessment
  • Cardiac surgery: SAVR candidacy, surgical risk evaluation
  • Operating surgeon: surgical urgency, timing flexibility
  • Anesthesia: intraoperative hemodynamic strategy, monitoring plan, postoperative destination

The topics for this discussion include: whether valve intervention should precede non-cardiac surgery, the surgical timeline, the intraoperative monitoring strategy, and whether postoperative ICU care is indicated.

Basis for this approach

ACC/AHA 2021 Guideline for the Management of Patients With Valvular Heart Disease / ESC 2022 Guidelines on Cardiovascular Assessment and Management of Patients Undergoing Non-cardiac Surgery / JCS/JSEC 2020 Guidelines for Management of Valvular Heart Disease

Symptomatic severe AS (NYHA II, preserved LVEF). How do you proceed?

  1. 1.

    The most important decisions are about symptoms, urgency, and who needs to be in the conversation — not another valve measurement.

  2. 2.

    Preserved LVEF does not neutralize severe valve obstruction. Fixed cardiac output in the perioperative setting carries significant hemodynamic risk.

  3. 3.

    Emergency surgery with severe AS requires specialized anesthesia planning. The same principles apply — but the timeline is compressed and team coordination becomes critical.

Teaching points

  • The question is not whether the valve is severe. The question is what severe AS means for this specific operation.
  • Symptoms matter more than another echocardiographic measurement — in severe AS, symptom status defines the urgency of valve intervention.
  • Surgical urgency often determines the management strategy more than the valve gradient. Elective and emergency cases require entirely different approaches.
  • A normal ejection fraction does not eliminate the risk of severe AS — it confirms that obstruction is the dominant problem, not pump failure.
  • Perioperative planning begins after diagnosis. The most important question is: who needs to be in this conversation?